{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:50:55Z","timestamp":1792590655599,"version":"4.5.0"},"reference-count":36,"publisher":"MyJove Corporation","issue":"232","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70405","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:00:47Z","timestamp":1781046047000},"source":"Crossref","is-referenced-by-count":0,"title":["Current Incidence and Risk Factors for Polymyxin B-Associated Acute Kidney Injury In Patients With Septic Shock"],"prefix":"10.3791","author":[{"given":"Yuxia","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1159\/000063766","type":"journal-article","article-title":"Emergence of the concept of acute renal failure","volume":"22","author":"Eknoyan","year":"2002","unstructured":"Eknoyan, G. Emergence of the concept of acute renal failure. Am J Nephrol. 22, 225\u2013230 (2002).","journal-title":"Am J Nephrol"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2004090740","type":"journal-article","article-title":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients","volume":"16","author":"Chertow","year":"2005","unstructured":"Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V., Bates, D. W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 16, 3365\u20133370 (2005).","journal-title":"J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1097\/01.CCM.0000224227.70642.4F","type":"journal-article","article-title":"An assessment of the RIFLE criteria for acute renal failure in hospitalized patients","volume":"34","author":"Uchino","year":"2006","unstructured":"Uchino, S., Bellomo, R., Goldsmith, D., Bates, S., Ronco, C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 34, 1913\u20131917 (2006).","journal-title":"Crit Care Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.1996.03530430033035","type":"journal-article","article-title":"The effect of acute renal failure on mortality: a cohort analysis","volume":"275","author":"Levy","year":"1996","unstructured":"Levy, E. M., Viscoli, C. M., Horwitz, R. I. The effect of acute renal failure on mortality: a cohort analysis. JAMA. 275, 1489\u20131494 (1996).","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/cc4915","type":"journal-article","article-title":"RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients","volume":"10","author":"Hoste","year":"2006","unstructured":"Hoste, E. A. et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients. Crit Care. 10, R73 (2006).","journal-title":"Crit Care"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/14656566.2018.1559817","type":"journal-article","article-title":"The use of polymyxins to treat carbapenem-resistant infections in neonates and children","volume":"20","author":"Thomas","year":"2019","unstructured":"Thomas, R. et al. The use of polymyxins to treat carbapenem-resistant infections in neonates and children. Expert Opin Pharmacother. 20, 415\u2013422 (2019).","journal-title":"Expert Opin Pharmacother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jgar.2020.12.026","type":"journal-article","article-title":"Clinical use of intravenous polymyxin B for multidrug-resistant Gram-negative infections","volume":"24","author":"Falagas","year":"2021","unstructured":"Falagas, M. E. et al. Clinical use of intravenous polymyxin B for multidrug-resistant Gram-negative infections. J Glob Antimicrob Resist. 24, 342\u2013359 (2021).","journal-title":"J Glob Antimicrob Resist"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1111\/jam.15130","type":"journal-article","article-title":"Carbapenem resistance in Acinetobacter baumannii and its importance","volume":"131","author":"Nguyen","year":"2021","unstructured":"Nguyen, M., Joshi, S. G. Carbapenem resistance in Acinetobacter baumannii and its importance. J Appl Microbiol. 131, 2715\u20132738 (2021).","journal-title":"J Appl Microbiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.2147\/IDR.S337611","type":"journal-article","article-title":"Emerging carbapenem-resistant Enterobacteriaceae infections","volume":"14","author":"Tilahun","year":"2021","unstructured":"Tilahun, M. et al. Emerging carbapenem-resistant Enterobacteriaceae infections. Infect Drug Resist. 14, 4363\u20134374 (2021).","journal-title":"Infect Drug Resist"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/cid\/ciaa122","type":"journal-article","article-title":"Carbapenem-resistant enterobacterales terminology update","volume":"71","author":"Livermore","year":"2020","unstructured":"Livermore, D. M. et al. Carbapenem-resistant enterobacterales terminology update. Clin Infect Dis. 71, 1776\u20131782 (2020).","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nature.2017.21550","type":"journal-article","article-title":"The drug-resistant bacteria that pose the greatest health threats","volume":"543","author":"Willyard","year":"2017","unstructured":"Willyard, C. The drug-resistant bacteria that pose the greatest health threats. Nature. 543, 15 (2017).","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12941-015-0062-8","type":"journal-article","article-title":"High-dose colistin therapy and nephrotoxicity","volume":"14","author":"Omrani","year":"2015","unstructured":"Omrani, A. S. et al. High-dose colistin therapy and nephrotoxicity. Ann Clin Microbiol Antimicrob. 14, 3 (2015).","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/cc2358","type":"journal-article","article-title":"Intravenous colistin in critically ill patients","volume":"7","author":"Markou","year":"2003","unstructured":"Markou, N. et al. Intravenous colistin in critically ill patients. Crit Care. 7, 80\u201383 (2003).","journal-title":"Crit Care"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jinf.2012.01.015","type":"journal-article","article-title":"Predictors of AKI with polymyxin B","volume":"65","author":"Kubin","year":"2012","unstructured":"Kubin, C. J., Ellman, T. M., Phadke, V., Haynes, L. J., Calfee, D. P., Yin, M. T. Predictors of AKI with polymyxin B. J Infect. 65, 80\u201387 (2012).","journal-title":"J Infect"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0972-5229.45074","type":"journal-article","article-title":"Safety of polymyxin B in severe sepsis","volume":"12","author":"Ramasubban","year":"2008","unstructured":"Ramasubban, S., Majumdar, A., Das, P.S. Safety of polymyxin B in severe sepsis. Indian J Crit Care Med. 12, 153\u2013157 (2008).","journal-title":"Indian J Crit Care Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","type":"journal-article","article-title":"Acute renal failure definition and outcomes","volume":"8","author":"Bellomo","year":"2004","unstructured":"Bellomo, R. et al. Acute renal failure definition and outcomes. Crit Care. 8, R204\u2013R212 (2004).","journal-title":"Crit Care"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","type":"journal-article","article-title":"Acute Kidney Injury Network report","volume":"11","author":"Mehta","year":"2007","unstructured":"Mehta, R. L. et al. Acute Kidney Injury Network report. Crit Care. 11, R31 (2007).","journal-title":"Crit Care"},{"key":"ref18","first-page":"1","type":"journal-article","article-title":"KDIGO Clinical Practice Guideline for Acute Kidney Injury","volume":"2","year":"2012","unstructured":"KDIGO Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2, 1\u2013138 (2012).","journal-title":"Kidney Int Suppl"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ndt\/gfs380","type":"journal-article","article-title":"Biomarkers for AKI diagnosis","volume":"28","author":"Vanmassenhove","year":"2013","unstructured":"Vanmassenhove, J., Vanholder, R., Nagler, E., Van Biesen, W. Biomarkers for AKI diagnosis. Nephrol Dial Transplant. 28, 254\u2013273 (2013).","journal-title":"Nephrol Dial Transplant"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1681\/ASN.2010080796","type":"journal-article","article-title":"Biological markers of AKI","volume":"22","author":"Siew","year":"2011","unstructured":"Siew, E. D., Ware, L. B., Ikizler, T. A. Biological markers of AKI. J Am Soc Nephrol. 22, 810\u2013820 (2011).","journal-title":"J Am Soc Nephrol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/sj.ki.5002729","type":"journal-article","article-title":"Biomarkers for AKI diagnosis","volume":"73","author":"Coca","year":"2008","unstructured":"Coca, S. G., Yalavarthy, R., Concato, J., Parikh, C. R. Biomarkers for AKI diagnosis. Kidney Int. 73, 1008\u20131016 (2008).","journal-title":"Kidney Int"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1515\/CCLM.2011.664","type":"journal-article","article-title":"New biomarkers for AKI","volume":"49","author":"Soni","year":"2011","unstructured":"Soni, S. S., Pophale, R., Ronco, C. New biomarkers for AKI. Clin Chem Lab Med. 49, 1257\u20131263 (2011).","journal-title":"Clin Chem Lab Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.jacc.2014.09.066","type":"journal-article","article-title":"Biomarkers after cardiac surgery","volume":"64","author":"Basu","year":"2014","unstructured":"Basu, R. K. et al. Biomarkers after cardiac surgery. J Am Coll Cardiol. 64, 2753\u20132762 (2014).","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jcrc.2013.01.009","type":"journal-article","article-title":"Biomarker panel for AKI detection","volume":"28","author":"Katagiri","year":"2013","unstructured":"Katagiri, D. et al. Biomarker panel for AKI detection. J Crit Care. 28, 564\u2013570 (2013).","journal-title":"J Crit Care"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.athoracsur.2011.10.048","type":"journal-article","article-title":"Urinary biomarkers for AKI prediction","volume":"93","author":"Katagiri","year":"2012","unstructured":"Katagiri, D. et al. Urinary biomarkers for AKI prediction. Ann Thorac Surg. 93, 577\u2013583 (2012).","journal-title":"Ann Thorac Surg"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/ki.2012.173","type":"journal-article","article-title":"\u03b2-catenin in AKI","volume":"82","author":"Zhou","year":"2012","unstructured":"Zhou, D., Li, Y., Lin, L., Zhou, L., Igarashi, P., Liu, Y. \u03b2-catenin in AKI. Kidney Int. 82, 537\u2013547 (2012).","journal-title":"Kidney Int"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2010111124","type":"journal-article","article-title":"Gold standards in AKI biomarkers","volume":"23","author":"Waikar","year":"2012","unstructured":"Waikar, S. S., Betensky, R. A., Emerson, S. C., Bonventre, J. V. Gold standards in AKI biomarkers. J Am Soc Nephrol. 23, 13\u201321 (2012).","journal-title":"J Am Soc Nephrol"},{"key":"ref28","first-page":"3812","type":"journal-article","article-title":"Baseline creatinine in AKI","volume":"25","author":"Gai\u00e3o","year":"2010","unstructured":"Gai\u00e3o, S., Cruz, D.N. Baseline creatinine in AKI. Nephrol Dial Transplant. 25, 3812\u20133814 (2010).","journal-title":"Nephrol Dial Transplant"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/ndt\/gfr099","type":"journal-article","article-title":"Baseline creatinine challenges","volume":"26","author":"Pickering","year":"2011","unstructured":"Pickering, J. W., Endre, Z. H. Baseline creatinine challenges. Nephrol Dial Transplant. 26, 2056 (2011).","journal-title":"Nephrol Dial Transplant"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2215\/CJN.08531109","type":"journal-article","article-title":"MDRD misclassification of AKI","volume":"5","author":"Pickering","year":"2010","unstructured":"Pickering, J. W., Endre, Z. H. MDRD misclassification of AKI. Clin J Am Soc Nephrol. 5, 1165\u20131173 (2010).","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","type":"journal-article","article-title":"Polymyxin guidelines","volume":"39","author":"Tsuji","year":"2019","unstructured":"Tsuji, B. T. et al. Polymyxin guidelines. Pharmacotherapy. 39, 10\u201339 (2019).","journal-title":"Pharmacotherapy"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/pharmrev.120.000020","type":"journal-article","article-title":"Polymyxin challenges","volume":"73","author":"Nang","year":"2021","unstructured":"Nang, S. C. et al. Polymyxin challenges. Pharmacol Rev. 73, 679\u2013728 (2021).","journal-title":"Pharmacol Rev"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijantimicag.2018.10.020","type":"journal-article","article-title":"Colistin meta-analysis","volume":"53","author":"Wang","year":"2019","unstructured":"Wang, J., Niu, H., Wang, R., Cai, Y. Colistin meta-analysis. Int J Antimicrob Agents. 53, 383\u2013400 (2019).","journal-title":"Int J Antimicrob Agents"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40264-019-00873-8","type":"journal-article","article-title":"AKI pharmacovigilance study","volume":"43","author":"Patek","year":"2020","unstructured":"Patek, T. M., Teng, C., Kennedy, K. E., Alvarez, C. A., Frei, C. R. AKI pharmacovigilance study. Drug Saf. 43, 17\u201322 (2020).","journal-title":"Drug Saf"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2147\/IDR.S363944","type":"journal-article","article-title":"Polymyxin B AKI risk factors","volume":"15","author":"Jia","year":"2022","unstructured":"Jia, X., Guo, C., Yin, Z., Zhang, W., Du, S., Zhang, X. Polymyxin B AKI risk factors. Infect Drug Resist. 15, 1957\u20131965 (2022).","journal-title":"Infect Drug Resist"},{"key":"ref36","first-page":"e44301","type":"journal-article","article-title":"Polymyxin B nephrotoxicity","volume":"15","author":"\u00d6zkaraka\u015f","year":"2023","unstructured":"\u00d6zkaraka\u015f, H. et al. Polymyxin B nephrotoxicity. Cureus. 15, e44301 (2023).","journal-title":"Cureus"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/70405\/current-incidence-risk-factors-for-polymyxin-b-associated-acute","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:34:39Z","timestamp":1792589679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70405\/current-incidence-risk-factors-for-polymyxin-b-associated-acute"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":36,"journal-issue":{"issue":"232","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70405","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]}}}